Can Investors Both Earn Returns and End Cancer?

Jul 19

Billions are pouring into cancer treatments around the world, so investors and funders discuss how institutional investors can access returns.

CFF

Immunome bets on Nectin’s antibodies for next-generation antibody drug conjugates